Correction to: Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype (Scandinavian Journal of Immunology, (2005), 61, (5), 10.1111/j.1365-3083.2005.01569.x);Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype

Scandinavian Journal of Immunology

Volumn 61, Issue 5, 2005, Pages 410-417

  Rao, V ^a,c   Dhar, N ^a,d   Shakila, H ^b   Singh, R ^a   Khera, A ^a   Jain, R ^a   Naseema, M ^b   Paramasivan, C N ^b   Narayanan, P R ^b   Ramanathan, V D ^b   Tyagi, A K ^a  

^a UNIVERSITY OF DELHI   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; LIPOPROTEIN; LIVE VACCINE; MYCOBACTERIUM TUBERCULOSIS LIPOPROTEIN; RECOMBINANT BCG VACCINE 19N; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PURIFICATION; ARTICLE; BCG VACCINATION; CELL FUNCTION; CELL POLARITY; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; EFFECTOR CELL; GENE OVEREXPRESSION; GUINEA PIG; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION PREVENTION; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH2 CELL; WILD TYPE;

EID: 21044441944     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12991     Document Type: Erratum

References (29)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione RC. Global burden of tuberculosis-estimated incidence, prevalence, and mortality by country. JAMA 1999;282:677-86.
2. Andersen AB, Brennan P. Proteins and antigens of Mycobacterium tuberculosis. In: Bloom BR, ed. Tuberculosis: Protection, Pathogenesis and Control. Washington, DC: ASM Press, 1994:307-22.
3. Mustafa AS. Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 2002;39:113-9.
4. Pal PG, Horwitz MA. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992;60:4781-92.
5. Rook GS, Barnass J, Mace S, Stanford JL. Responsiveness to live M. tuberculosis and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol 1986;63:105-10.
6. Hubbard RD, Flory CM, Collins FM. Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 1992; 87:94-8.
7. Faith A, Moreno R, Lathigra R et al. Analysis of human T cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR. Immunology 1991;74:1-7.
8. Harris D, Vordermeier H, Roman E et al. Murine T cell stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis: epitope restricted homology with the 28kDa protein of Mycobacterium leprae. J Immunol 1991;147:2706-12.
9. Brightbill HD, Linraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through Toll like receptors. Science 1999;285:732-0.
10. Pai RK, Convey M, Hamilton TA, Boom WH, Harding CV. Inhibition of IFN-gamma-induced class II transactivator expression by a 19 kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol 2003;171:175-84.
11. Noss EH, Pai RK, Sellati TJ et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001;167:910-8.
12. Neyrolles O, Gould K, Gares MP et al. Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria. J Immunol 2001;166:447-57.
13. Abou-Zeid C, Gares MP, Inwald J et al. Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun 1997;65:1856-62.
14. Yeremeev W, Stewart GR, Neyrolloes O et al. Deletion of 19 kDa antigen does not alter the protective efficacy of BCG. Tuber Lung Dis 2000;80:243-7.
15. Dhar N, Rao V, Tyagi AK. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant anrigens of M. tuberculosis. FEMS Microbiol Lett 2000;190:309-16.
16. DasGupta SK, Bashyam MD, Tyagi AK. Cloning and assessment of mycobacterial promoters by using a plasmid shuttle vector. J Bacteriol 1993;175:5186-92.
17. Dhar N, Rao V, Tyagi AK. Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system. Immunol Lett 2003;88:175-84.
18. DasGupta SK, Jain S, Kaushal D, Tyagi AK. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines. Biochem Biophys Res Commun 1998;246:797-804.
19. Rao V, Dhar N, Tyagi AK. Modulation of host immune responses by over-expression of immunodominant antigens of Mycobacterium tuberculosis in Bacille Calmette-Guerin. Scand J Immunol 2003; 58:449-61.
20. Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991;59:1558-63.
21. Mitchison DA. The virulence of tubercle bacilli from patients with pulmonary tuberculosis in India and other countries. Bull Int Union Tuberc Lung Dis 1964;35:287.
22. Jayashankar K, Ramanathan VD. Biochemical and histochemical changes relating to fibrosis following infection with Mycobacterium tuberculosis in the guinea pig. Indian J Med Res 1999;110:91-7.
23. Singh R, Rao V, Shakila H et al. Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol 2003;50:751-62.
24. Boesen H, Jensen BN, Wilcke T, Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 1995;63:1491-7.
25. Coler RN, Campos-Neto A, Ovendale P et al. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol 2001;166:6227-35.
26. Ravn P, Boesen H, Pedersen BK, Andersen P. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Immunol 1997;158:1949-55.
27. Huygen K, Content J, Denis O et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996;2:893-8.
28. Roberts AD, Sonnenberg MG, Ordway DJ et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995;85:502-8.
29. Orme IM. Immunity to mycobacteria. Curr Opin Immunol 1993;5:497-502.